Prevalence of Abnormal Systolic Blood Pressure (n = 21)
| First Author . | Country . | Ages (y) . | N . | Definition of Abnormal . | Subgroup (eg, M/F) . | Total . | Healthy . | Overweight . | Class I . | Class II . | Class III . | P . | Notes . | Weight Definitions . | Population Info . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ice | USA | 9–13 | 29286 | >95th | 7.9 | 13.4 | 23.4 | <.01 | Appalachian population | ||||||
| Davis | USA | 7–18 | 211 (160 for lipids) | >90th | 6 | 16 | 45 | <.001 | Rural Georgia | ||||||
| Bindler | USA | 11–14 | 151 | >90th | 2.9 | 17.1 | .003 | ||||||||
| Turconi | Italy | 14–17 | 532 | >95th | Males | 10.1 | 35.4 | ||||||||
| Females | 4.8 | 22.7 | |||||||||||||
| Skinner | USA | 6–17 | NR | >95th | 3.4 | 1.6 | 4.5 | 9.0 | <.01 | NHANES 2001–2002 | |||||
| Simsek | Turkey | Mean 10.8 | 115 | >95th | 0 | 13.3 | <.001 | OB >97th | |||||||
| Puri | USA | 10–18 | 198 | >95th | 3 | 28 | .002 | General pediatrics and endocrinology patients | |||||||
| Maggio | Switzerland | Mean 8.8 | 66 | >95th | 0 | 20.5 | .029 | OB >97th | |||||||
| Skinner | USA | 3–19 | 8579 | >95th | 3.22 | 5.02 | 8.52 | 11.10 | <.001 | NHANES 1999–2012 | |||||
| Maximova | Canada | 6–19 | 2087 | >75th | 6–11 y | 18 | 33.2 | NR | |||||||
| 12–19 y | 18 | 38.2 | NR | ||||||||||||
| Krzyzaniak | Poland | 10–18 | 4904 | ≥90th, 3 d | Males | 11.6 | 7.8 | 18.8 | 45.1 | .000 | |||||
| Females | 11.8 | 8.9 | 21.1 | 50.9 | .000 | ||||||||||
| Stray-Pederson | Norway | 15–18 | 2156 | >95th | 16.6% | ref | OR = 3.8 | OR = 28.3 | |||||||
| Kim | Korea | 10–18 | 1412 | >95th | 1998 KNHANES | 9.1 | 20.0 | 28.9 | <.05 | ||||||
| 1158 | 2001 KNHANES | 5.2 | 9.6 | 22.7 | <.05 | ||||||||||
| Botton | France | 8–17 | 452 | >95th | 3.2 | 13 | 0.01 | OW >90th | |||||||
| Harding | UK | 11–13 | 6407 | >95th | Males | 2.7 | OR = 1.0 | OR = 2.50 | OR = 4.31 | <.05 | |||||
| Females | 3.8 | OR = 1.0 | OR = 3.39 | OR = 5.68 | <.05 | ||||||||||
| Serap | Turkey | 6–16 | 284 | >95th | Males | 3.8 | 19.1 | <.001 | Pediatric endocrinology patients | ||||||
| Females | 4.3 | 16.5 | <.001 | ||||||||||||
| Messiah | USA | 8–14 | 1698 | >90th | 8–11 y | 4.97 | 14.81 | 19.02 | |||||||
| 12–14 y | 2.26 | 11.36 | 20.87 | ||||||||||||
| Lambert | Canada | 9–16 | 3613 | >90th | Males | 16.5 | 28.8 | 39.6 | <.0001 | ||||||
| >90th | Females | 11.8 | 27.4 | 40.6 | <.0001 | ||||||||||
| Avnieli Velfer | Israel | 2–18 | 1027 | >95th | Males | 32.5 | 41.5 | .03 | OB 95th, SO 120%/95th | Obesity clinic patients | |||||
| Females | 32.4 | 46.6 | <.001 | OB 95th, SO 120%/95th | Obesity clinic patients | ||||||||||
| Hadjiyannakis | Canada | 5–17 | 847 | >95th | 14 | 10 | 9 | 26 | NR | Pediatric weight management program patients | |||||
| Stolzman | USA | 12–17 | 62 | >90th | 3 | 13 | NS | Community recruitment |
| First Author . | Country . | Ages (y) . | N . | Definition of Abnormal . | Subgroup (eg, M/F) . | Total . | Healthy . | Overweight . | Class I . | Class II . | Class III . | P . | Notes . | Weight Definitions . | Population Info . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ice | USA | 9–13 | 29286 | >95th | 7.9 | 13.4 | 23.4 | <.01 | Appalachian population | ||||||
| Davis | USA | 7–18 | 211 (160 for lipids) | >90th | 6 | 16 | 45 | <.001 | Rural Georgia | ||||||
| Bindler | USA | 11–14 | 151 | >90th | 2.9 | 17.1 | .003 | ||||||||
| Turconi | Italy | 14–17 | 532 | >95th | Males | 10.1 | 35.4 | ||||||||
| Females | 4.8 | 22.7 | |||||||||||||
| Skinner | USA | 6–17 | NR | >95th | 3.4 | 1.6 | 4.5 | 9.0 | <.01 | NHANES 2001–2002 | |||||
| Simsek | Turkey | Mean 10.8 | 115 | >95th | 0 | 13.3 | <.001 | OB >97th | |||||||
| Puri | USA | 10–18 | 198 | >95th | 3 | 28 | .002 | General pediatrics and endocrinology patients | |||||||
| Maggio | Switzerland | Mean 8.8 | 66 | >95th | 0 | 20.5 | .029 | OB >97th | |||||||
| Skinner | USA | 3–19 | 8579 | >95th | 3.22 | 5.02 | 8.52 | 11.10 | <.001 | NHANES 1999–2012 | |||||
| Maximova | Canada | 6–19 | 2087 | >75th | 6–11 y | 18 | 33.2 | NR | |||||||
| 12–19 y | 18 | 38.2 | NR | ||||||||||||
| Krzyzaniak | Poland | 10–18 | 4904 | ≥90th, 3 d | Males | 11.6 | 7.8 | 18.8 | 45.1 | .000 | |||||
| Females | 11.8 | 8.9 | 21.1 | 50.9 | .000 | ||||||||||
| Stray-Pederson | Norway | 15–18 | 2156 | >95th | 16.6% | ref | OR = 3.8 | OR = 28.3 | |||||||
| Kim | Korea | 10–18 | 1412 | >95th | 1998 KNHANES | 9.1 | 20.0 | 28.9 | <.05 | ||||||
| 1158 | 2001 KNHANES | 5.2 | 9.6 | 22.7 | <.05 | ||||||||||
| Botton | France | 8–17 | 452 | >95th | 3.2 | 13 | 0.01 | OW >90th | |||||||
| Harding | UK | 11–13 | 6407 | >95th | Males | 2.7 | OR = 1.0 | OR = 2.50 | OR = 4.31 | <.05 | |||||
| Females | 3.8 | OR = 1.0 | OR = 3.39 | OR = 5.68 | <.05 | ||||||||||
| Serap | Turkey | 6–16 | 284 | >95th | Males | 3.8 | 19.1 | <.001 | Pediatric endocrinology patients | ||||||
| Females | 4.3 | 16.5 | <.001 | ||||||||||||
| Messiah | USA | 8–14 | 1698 | >90th | 8–11 y | 4.97 | 14.81 | 19.02 | |||||||
| 12–14 y | 2.26 | 11.36 | 20.87 | ||||||||||||
| Lambert | Canada | 9–16 | 3613 | >90th | Males | 16.5 | 28.8 | 39.6 | <.0001 | ||||||
| >90th | Females | 11.8 | 27.4 | 40.6 | <.0001 | ||||||||||
| Avnieli Velfer | Israel | 2–18 | 1027 | >95th | Males | 32.5 | 41.5 | .03 | OB 95th, SO 120%/95th | Obesity clinic patients | |||||
| Females | 32.4 | 46.6 | <.001 | OB 95th, SO 120%/95th | Obesity clinic patients | ||||||||||
| Hadjiyannakis | Canada | 5–17 | 847 | >95th | 14 | 10 | 9 | 26 | NR | Pediatric weight management program patients | |||||
| Stolzman | USA | 12–17 | 62 | >90th | 3 | 13 | NS | Community recruitment |
NR, not reported; NS, not significant; OB, obese; OR, odds ratio; OW, overweight; SO, severe obesity.